These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 17045397)

  • 1. International quality control survey of neurochemical dementia diagnostics.
    Lewczuk P; Beck G; Ganslandt O; Esselmann H; Deisenhammer F; Regeniter A; Petereit HF; Tumani H; Gerritzen A; Oschmann P; Schröder J; Schönknecht P; Zimmermann K; Hampel H; Bürger K; Otto M; Haustein S; Herzog K; Dannenberg R; Wurster U; Bibl M; Maler JM; Reubach U; Kornhuber J; Wiltfang J
    Neurosci Lett; 2006 Nov; 409(1):1-4. PubMed ID: 17045397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neurochemical dementia diagnostics for Alzheimer's disease and other dementias: an ISO 15189 perspective.
    Waedt J; Kleinow M; Kornhuber J; Lewczuk P
    Biomark Med; 2012 Oct; 6(5):685-90. PubMed ID: 23075248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of CSF biomarkers in the diagnostic work-up of mixed vascular-degenerative dementia.
    Engelborghs S; Le Bastard N
    J Neurol Sci; 2012 Nov; 322(1-2):197-9. PubMed ID: 22947896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Vanderstichele H; Bibl M; Engelborghs S; Le Bastard N; Lewczuk P; Molinuevo JL; Parnetti L; Perret-Liaudet A; Shaw LM; Teunissen C; Wouters D; Blennow K
    Alzheimers Dement; 2012 Jan; 8(1):65-73. PubMed ID: 22047631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurochemical dementia diagnostics: State of the art and research perspectives.
    Lewczuk P; Wiltfang J
    Proteomics; 2008 Mar; 8(6):1292-301. PubMed ID: 18271068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
    Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S
    J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Alzheimer's Association external quality control program for cerebrospinal fluid biomarkers.
    Mattsson N; Andreasson U; Persson S; Arai H; Batish SD; Bernardini S; Bocchio-Chiavetto L; Blankenstein MA; Carrillo MC; Chalbot S; Coart E; Chiasserini D; Cutler N; Dahlfors G; Duller S; Fagan AM; Forlenza O; Frisoni GB; Galasko D; Galimberti D; Hampel H; Handberg A; Heneka MT; Herskovits AZ; Herukka SK; Holtzman DM; Humpel C; Hyman BT; Iqbal K; Jucker M; Kaeser SA; Kaiser E; Kapaki E; Kidd D; Klivenyi P; Knudsen CS; Kummer MP; Lui J; Lladó A; Lewczuk P; Li QX; Martins R; Masters C; McAuliffe J; Mercken M; Moghekar A; Molinuevo JL; Montine TJ; Nowatzke W; O'Brien R; Otto M; Paraskevas GP; Parnetti L; Petersen RC; Prvulovic D; de Reus HP; Rissman RA; Scarpini E; Stefani A; Soininen H; Schröder J; Shaw LM; Skinningsrud A; Skrogstad B; Spreer A; Talib L; Teunissen C; Trojanowski JQ; Tumani H; Umek RM; Van Broeck B; Vanderstichele H; Vecsei L; Verbeek MM; Windisch M; Zhang J; Zetterberg H; Blennow K
    Alzheimers Dement; 2011 Jul; 7(4):386-395.e6. PubMed ID: 21784349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Added diagnostic value of CSF biomarkers in differential dementia diagnosis.
    Le Bastard N; Martin JJ; Vanmechelen E; Vanderstichele H; De Deyn PP; Engelborghs S
    Neurobiol Aging; 2010 Nov; 31(11):1867-76. PubMed ID: 19150153
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical dementia diagnostics in Alzheimer's disease: where are we now and where are we going?
    Lewczuk P; Kornhuber J
    Expert Rev Proteomics; 2011 Aug; 8(4):447-58. PubMed ID: 21819301
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid Aβ1-40 improves differential dementia diagnosis in patients with intermediate P-tau181P levels.
    Slaets S; Le Bastard N; Martin JJ; Sleegers K; Van Broeckhoven C; De Deyn PP; Engelborghs S
    J Alzheimers Dis; 2013; 36(4):759-67. PubMed ID: 23666174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pre-analytical and analytical factors influencing Alzheimer's disease cerebrospinal fluid biomarker variability.
    Fourier A; Portelius E; Zetterberg H; Blennow K; Quadrio I; Perret-Liaudet A
    Clin Chim Acta; 2015 Sep; 449():9-15. PubMed ID: 26141614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved discrimination of autopsy-confirmed Alzheimer's disease (AD) from non-AD dementias using CSF P-tau(181P).
    Koopman K; Le Bastard N; Martin JJ; Nagels G; De Deyn PP; Engelborghs S
    Neurochem Int; 2009 Sep; 55(4):214-8. PubMed ID: 19524111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inter-laboratory variation in cerebrospinal fluid biomarkers for Alzheimer's disease: united we stand, divided we fall.
    Mattsson N; Blennow K; Zetterberg H
    Clin Chem Lab Med; 2010 May; 48(5):603-7. PubMed ID: 20201744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiplexed quantification of dementia biomarkers in the CSF of patients with early dementias and MCI: a multicenter study.
    Lewczuk P; Kornhuber J; Vanderstichele H; Vanmechelen E; Esselmann H; Bibl M; Wolf S; Otto M; Reulbach U; Kölsch H; Jessen F; Schröder J; Schönknecht P; Hampel H; Peters O; Weimer E; Perneczky R; Jahn H; Luckhaus C; Lamla U; Supprian T; Maler JM; Wiltfang J
    Neurobiol Aging; 2008 Jun; 29(6):812-8. PubMed ID: 17239996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Alzheimer's disease biological misdiagnosis linked to cerebrospinal collection tubes.
    Perret-Liaudet A; Pelpel M; Tholance Y; Dumont B; Vanderstichele H; Zorzi W; Elmoualij B; Schraen S; Moreaud O; Gabelle A; Thouvenot E; Thomas-Anterion C; Touchon J; Krolak-Salmon P; Kovacs GG; Coudreuse A; Quadrio I; Lehmann S
    J Alzheimers Dis; 2012; 31(1):13-20. PubMed ID: 22495345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The load of amyloid-β oligomers is decreased in the cerebrospinal fluid of Alzheimer's disease patients.
    Sancesario GM; Cencioni MT; Esposito Z; Borsellino G; Nuccetelli M; Martorana A; Battistini L; Sorge R; Spalletta G; Ferrazzoli D; Bernardi G; Bernardini S; Sancesario G
    J Alzheimers Dis; 2012; 31(4):865-78. PubMed ID: 22717612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter study.
    Lewczuk P; Kamrowski-Kruck H; Peters O; Heuser I; Jessen F; Popp J; Bürger K; Hampel H; Frölich L; Wolf S; Prinz B; Jahn H; Luckhaus Ch; Perneczky R; Hüll M; Schröder J; Kessler H; Pantel J; Gertz HJ; Klafki HW; Kölsch H; Reulbach U; Esselmann H; Maler JM; Bibl M; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2010 Feb; 15(2):138-45. PubMed ID: 18663368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?
    Zetterberg H; Blennow K
    J Alzheimers Dis; 2013; 33 Suppl 1():S361-9. PubMed ID: 22710917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Alzheimer's Association international guidelines for handling of cerebrospinal fluid for routine clinical measurements of amyloid β and tau.
    Hansson O; Batrla R; Brix B; Carrillo MC; Corradini V; Edelmayer RM; Esquivel RN; Hall C; Lawson J; Bastard NL; Molinuevo JL; Nisenbaum LK; Rutz S; Salamone SJ; Teunissen CE; Traynham C; Umek RM; Vanderstichele H; Vandijck M; Wahl S; Weber CJ; Zetterberg H; Blennow K
    Alzheimers Dement; 2021 Sep; 17(9):1575-1582. PubMed ID: 33788410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.